List of works - Isabella Caligiuri

4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors

scientific article

A Guide to PIN1 Function and Mutations Across Cancers

scientific article published on 01 January 2018

A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017).

scientific article

Androgen receptor serine 81 mediates Pin1 interaction and activity

scientific article

Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors.

scientific article

Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy.

scientific article published on 13 January 2017

CDK inhibitors: from the bench to clinical trials.

scientific article published on March 2010

Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer.

scientific article

Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors

scientific article published on 01 December 2019

Critical choices for modeling breast cancer in transgenic mouse models.

scientific article published on August 2012

Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors.

scientific article

Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors

scientific article published on 16 August 2018

Dissecting Pin1 and phospho-pRb regulation.

scientific article published on January 2013

Enhanced Chemotherapeutic Behavior of Open-Caged DNA@Doxorubicin Nanostructures for Cancer Cells

scientific article published on 29 May 2015

Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin

scientific article published on 30 September 2015

Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models.

scientific article published on 25 August 2016

First-of-its-kind STARD3 Inhibitor: In Silico Identification and Biological Evaluation as Anticancer Agent

scientific article published on 20 February 2019

Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model

scientific article

Identification and characterization of a new reversible MAGL inhibitor

scientific article

Identification of new Fyn kinase inhibitors using a FLAP-based approach.

scientific article

Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer

scientific article published on 08 May 2018

New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents

scientific article published on 01 December 2019

Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor

scientific article published on 11 February 2019

Pin1 and nuclear receptors: a new language?

scientific article published on September 2013

Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of Doxorubicin

scientific article published on 31 January 2019

Rational Development of MAGL Inhibitors

scientific article published on 01 January 2018

Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1.

scientific article

Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)<sub>2</sub> NS) for Ovarian Cancer Therapy

scientific article published on 19 October 2021

Synthesis and in-depth studies on the anticancer activity of novel palladacyclopentadienyl complexes stabilized by N-Heterocyclic carbene ligands

scientific article published on 22 June 2019

The Clinical translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.

scientific article published on 29 August 2017

The prolyl isomerase Pin1 acts synergistically with CDK2 to regulate the basal activity of estrogen receptor α in breast cancer

scientific article

Treatment for glioma recurrence: new hope?

scientific article

Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects

scientific article published on 29 January 2019

pRb controls estrogen receptor alpha protein stability and activity.

scientific article published on June 2013

List of works by Isabella Caligiuri

4-Aryliden-2-methyloxazol-5(4H)-one as a new scaffold for selective reversible MAGL inhibitors

A Guide to PIN1 Function and Mutations Across Cancers

A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017).

Androgen receptor serine 81 mediates Pin1 interaction and activity

Binding investigation and preliminary optimisation of the 3-amino-1,2,4-triazin-5(2H)-one core for the development of new Fyn inhibitors.

Bottom-up synthesis of carbon nanoparticles with higher doxorubicin efficacy.

CDK inhibitors: from the bench to clinical trials.

Characterization of the Saffron Derivative Crocetin as an Inhibitor of Human Lactate Dehydrogenase 5 in the Antiglycolytic Approach against Cancer.

Computationally driven discovery of phenyl(piperazin-1-yl)methanone derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors

Critical choices for modeling breast cancer in transgenic mouse models.

Development of terphenyl-2-methyloxazol-5(4H)-one derivatives as selective reversible MAGL inhibitors.

Discovery of long-chain salicylketoxime derivatives as monoacylglycerol lipase (MAGL) inhibitors

Dissecting Pin1 and phospho-pRb regulation.

Enhanced Chemotherapeutic Behavior of Open-Caged DNA@Doxorubicin Nanostructures for Cancer Cells

Exosomal doxorubicin reduces the cardiac toxicity of doxorubicin

Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models.

First-of-its-kind STARD3 Inhibitor: In Silico Identification and Biological Evaluation as Anticancer Agent

Highly selective salicylketoxime-based estrogen receptor β agonists display antiproliferative activities in a glioma model

Identification and characterization of a new reversible MAGL inhibitor

Identification of new Fyn kinase inhibitors using a FLAP-based approach.

Liposomal delivery of a Pin1 inhibitor complexed with cyclodextrins as new therapy for high-grade serous ovarian cancer

New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents

Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor

Pin1 and nuclear receptors: a new language?

Proof-of-Concept Multistage Biomimetic Liposomal DNA Origami Nanosystem for the Remote Loading of Doxorubicin

Rational Development of MAGL Inhibitors

Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1.

Self-Therapeutic Cobalt Hydroxide Nanosheets (Co(OH)<sub>2</sub> NS) for Ovarian Cancer Therapy

Synthesis and in-depth studies on the anticancer activity of novel palladacyclopentadienyl complexes stabilized by N-Heterocyclic carbene ligands

The Clinical translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.

The prolyl isomerase Pin1 acts synergistically with CDK2 to regulate the basal activity of estrogen receptor α in breast cancer

Treatment for glioma recurrence: new hope?

Virtual screening identifies a PIN1 inhibitor with possible antiovarian cancer effects

pRb controls estrogen receptor alpha protein stability and activity.